One more. The World Health Organization (WHO) gave its emergency approval for the Chinese vaccine against Covid-19 Sinovac on Tuesday, June 1, the UN agency said in a press release. The WHO vaccine expert committee has recommended this vaccine, which requires two doses at two to four week intervals for people 18 years of age and older.
>> Follow the latest information on Covid-19 in our direct
“The world is in desperate need of many Covid 19 vaccines to deal with the huge inequalities around the world”, said Dr Mariangela Simao, WHO Assistant Director-General for Access to Medicines and Health Products.
The effectiveness of Sinovac is 51% to prevent symptomatic Covid cases but 100% to avoid the most serious cases and hospitalizations, on the populations studied, specifies the WHO. Effectiveness for those over 60 years of age could not be assessed.
It is the second Chinese vaccine to obtain the green light from the WHO, and it can thus integrate the Covax international system for the distribution of anti-Covid vaccines, especially in disadvantaged countries. The WHO had already approved the Sinopharm, manufactured in Beijing, on May 7.
The organization has also already given the green light for Moderna’s vaccine, Pfizer-BioNTech’s vaccine, two AstraZeneca products manufactured in India and South Korea (WHO counts this for two approvals even though the product is identical) and Janssen from Johnson & Johnson.